Skip to content

A Prospective Cohort Study on Acupuncture Treatment and the Induction of Attention Deficit by Chronic Insomnia

A prospective cohort study on the effect of acupuncture treatment on attention deficit induced by chronic insomnia

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ITMCTR
Registry ID
ITMCTR2025001161
Enrollment
Unknown
Registered
2025-06-12
Start date
2025-05-27
Completion date
Unknown
Last updated
2025-06-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic insomnia leads to attention deficit

Interventions

Non-exposed group:Administer the drug as recommended in the guidelines
Exposure group:Acupuncture

Sponsors

Chengdu Fifth People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
20 Years to 60 Years

Inclusion criteria

Inclusion criteria: 1) Age: 20 - 60 years old gender not restricted educational attainment = 9 years; 2) Meets the diagnostic criteria for chronic insomnia accompanied by attention deficit; 3) Pittsburgh Sleep Quality Index (PSQI) score > 7 points; 4) The subject can cooperate and complete sleep breathing monitoring; 5) The subject can cooperate and complete multiple subtests of attention functions: Montreal Cognitive Assessment (MoCA) attention subtest adult Wechsler Memory Scale central intelligence test (1?100 and 100?1 continuous addition test) digit span visual memory span test (picture recall visual recognition visual reproduction) etc. subtests; 6) In the past two weeks has not taken hypnotic drugs sedatives antipsychotic drugs (anxiety depression etc. drugs) and other drugs that affect sleep and attention and other cognitive abilities; 7) No patients with severe heart liver kidney dysfunction or mental disorders; 8)Communication is unobstructed and the individual can cooperate to complete the efficacy evaluation. 9)Voluntarily participate in this trial and sign the informed consent form.

Exclusion criteria

Exclusion criteria: 1) Those who have suffered from brain trauma and neurological damage recently; 2) Those with liver and kidney function impairment malignant tumors chronic pain infections related thyroid diseases and other serious internal diseases or mental disorders (such as bipolar disorder anxiety and depression disorders etc.); 3) Those with neurodegenerative diseases (such as Parkinson's disease Alzheimer's disease etc.); 4) Those with sleep-related disorders indicated by polysomnography such as subjective insomnia and periodic limb movement; 5) Pregnant or lactating patients; 6) Those who have taken sedative drugs that may affect sleep mood and cognitive functions within the last two weeks; 7) Those who have received acupuncture massage or other related treatments within the past month; 8) Those who cannot cooperate with relevant examinations; 9) Those with visual or hearing impairments and unable to complete related tests; (Notes: Any patient who meets any of the above criteria will be excluded.)

Design outcomes

Primary

MeasureTime frame
The attention subtest of the Montreal Cognitive Assessment Scale;Pittsburgh Sleep Quality Index;

Secondary

MeasureTime frame
Hamilton Depression Scale;Hamilton Anxiety Scale;Multi-channel sleep breathing monitoring;The attention subtest of the Adult Wechsler Memory Scale;Severe Insomnia Severity Index Scale;

Countries

the People's Republic of China

Contacts

Public ContactGuolong Gao

Medical Research and Translation Center of the Fifth People's Hospital of Chengdu City

gaoguolong2013@163.com13908226721

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026